• Net revenue increased 46% over prior-year period to $21.1 million due to strength of semiconductor and industrial markets; multimarket revenue grew 22% sequentially
  • Solid margins resulted in earnings per diluted share of $0.20, in line with guidance
  • Generated strong cash from operations of $4.3 million in the quarter and $8.1 million year-to-date
  • Advancing growth strategy with two acquisitions completed subsequent to quarter end; expected to be more than $0.05 accretive to diluted earnings per share in the first year
  • Increased financial flexibility with new credit facility and enhanced capital structure with low-cost term borrowing following quarter end

MT. LAUREL, N.J.–(BUSINESS WIRE)–inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets, including automotive, defense/aerospace, industrial, life sciences, semiconductor and telecommunications, today announced financial results for the quarter ended September 30, 2021.

inTEST Reports 46% Revenue Growth and Advances 5-Point Strategy in Third Quarter 2021

“We delivered solid third quarter results that we believe demonstrate that we are successfully executing on our 5-Point Strategy, which is focused on driving growth and diversifying our markets and customer base. Multimarket revenue grew 22% sequentially and while our semiconductor business declined sequentially, it remains at historically high levels. Our strong margins and net income were in our expected range even as we continue to manage the ongoing challenges of supply chain constraints. Of note, we continued to generate strong cash flow in the quarter and improved our financial flexibility subsequent to quarter end with a new credit facility that will support our long-term strategy,” commented Nick Grant, President and CEO.

Mr. Grant added, “Following the end of the third quarter, we successfully closed two acquisitions in support of our 5-Point Strategy. Each adds to our product platform offerings and technical expertise, while expanding our customer base to adjacent, high-growth markets. Importantly, we believe we can scale these businesses with targeted investments and benefit from secular tailwinds in the life sciences markets.

“While acquisitions will continue to be a key element of our 5-Point Strategy, we are also focused on driving organic growth. We believe our new product development efforts combined with a robust pipeline of new customer opportunities provide catalysts for further differentiation of our business and growth in revenue and profitability over the long-term.”

Third Quarter 2021 Revenue

($ in 000s)

Three Months Ended

Change

Change

9/30/2021

6/30/2021

$

%

9/30/2020

$

%

Net Revenue

Multimarket (1)

$

7,488

35.4%

$

6,143

28.2%

$

1,345

21.9%

$

7,056

48.9%

$

432

6.1%

Semi Market (2)

 

13,656

64.6%

 

15,677

71.8%

 

(2,021)

-12.9%

 

7,387

51.1%

 

6,269

84.9%

$

21,144

100.0%

$

21,820

100.0%

$

(676)

-3.1%

$

14,443

100.0%

$

6,701

46.4%

  1. Multimarket: These amounts include all net revenue from markets other than the semiconductor market.
  2. Semi Market: These amounts include all net revenue from the semiconductor market.

The increase in multimarket revenue reflects the ongoing, broad-based recovery within industrial sectors. The Company also has benefited from new product introductions and the reopening of trade shows, which has resulted in new customer opportunities and wins. The electric vehicle market continues to gain traction with a variety of applications for inTEST’s induction heating technology.

Semi market revenue remained robust as global demand for semiconductors continues to drive investment in the industry.

The Company’s top 5 customers represented approximately 36% of third quarter net revenue with the largest customer representing approximately 14%.

Third Quarter 2021 Operating Results

 

Three Months Ended

($ in 000s)

     

Change

   

Change

 

9/30/2021

6/30/2021

$

%

 

9/30/2020

$

 

%

Gross profit

 

$

10,395

 

$

10,962

 

$

(567)

-5.2%

 

$

6,450

 

$

3,945

 

61.2%

Gross margin

 

 

49.2%

 

 

50.2%

   

 

44.7%

   
             

Operating income

 

$

2,549

 

$

3,035

 

$

(486)

-16.0%

 

$

427

 

$

2,122

 

497.0%

Operating margin

 

 

12.1%

 

 

13.9%

   

 

3.0%

   
             

Net earnings (GAAP)

 

$

2,175

 

$

2,609

 

$

(434)

-16.6%

 

$

458

 

$

1,717

 

374.9%

Net earnings per diluted share (GAAP)

 

$

0.20

 

$

0.24

   

$

0.04

   
             

Adjusted net earnings (Non-GAAP) (1)

 

$

2,480

 

$

2,910

 

$

(430)

-14.8%

 

$

750

 

$

1,730

 

230.7%

Adjusted net earnings per diluted share

(Non-GAAP) (1)

 

$

0.23

 

$

0.27

   

$

0.07

   

Adjusted EBITDA (Non-GAAP) (1)

 

$

3,388

 

$

3,984

 

$

(596)

-15.0%

 

$

993

 

$

2,395

 

241.2%

Adjusted EBITDA margin (Non-GAAP) (1)

 

 

16.0%

 

 

18.3%

   

 

6.9%

   
  1. Adjusted net earnings, adjusted net earnings per diluted share, adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. Further information can be found under “Non-GAAP Financial Measures.” See also the reconciliations of GAAP financial measures to non-GAAP financial measures that accompany this press release.

The sequential change in gross margin reflected higher component material costs not yet fully covered by price improvements as well as changes in product mix and less favorable absorption of fixed manufacturing costs. Year-over-year improvement in gross margin reflects higher volume and improved product mix.

Compared with the second quarter of 2021, selling expense was up $236,000, or 9%, to $2.8 million, primarily reflecting increased headcount, a return to more normal levels of travel as restrictions are lifted, and an increase in spending on new advertising initiatives. Engineering and product development expense remained relatively unchanged compared with the trailing period.

General and administrative expense decreased $149,000, or 4%, compared with the second quarter, while restructuring and other charges decreased $146,000, or 74%, sequentially. The second quarter expense included $347,000 related to non-recurring CFO transition costs. The decrease in CFO transition related costs was partially offset by an increase in expenses related to merger and acquisition activities during the third quarter.

Balance Sheet and Cash Flow Review

Cash and cash equivalents at the end of the third quarter were $18.7 million, up $4.1 million, or 28%, from

June 30, 2021. During the quarter, the Company generated $4.3 million of cash from operations.

In October 2021, inTEST executed a new five-year credit agreement that includes a $25 million non-revolving delayed draw term loan and a $10 million revolving credit facility that replaced its previous $10 million facility, which had no borrowings at the end of the third quarter of 2021. Subsequent to quarter end, the Company used $12 million of its new credit facility and $500,000 in cash for the two acquisitions announced in October, excluding acquisition costs.

Capital expenditures during the third quarter were $114,000, up from $75,000 in the second quarter.

 

Orders and Backlog Summary

($ in 000s)

Three Months Ended

   

Change

 

Change

9/30/2021

 

6/30/2021

 

$

 

%

9/30/2020

$

 

%

Orders

         

Multimarket

$

7,783

36.8%

 

$

8,573

34.1%

 

$

(790)

 

-9.2%

$

7,164

 

49.7%

$

619

 

8.6%

Semi Market

 

13,365

63.2%

 

 

16,532

65.9%

 

 

(3,167)

 

-19.2%

 

7,263

 

50.3%

 

6,102

 

84.0%

$

21,148

100.0%

 

$

25,105

100.0%

 

$

(3,957)

 

-15.8%

$

14,427

 

100.0%

$

6,721

 

46.6%

           

As of

   

Change

 

Change

9/30/2021

 

6/30/2021

 

$

 

%

9/30/2020

 

$

 

%

           

Backlog

$

20,428

 

$

20,424

 

$

4

 

0.0%

$

8,722

 

 

11,706

 

134.2%

Demand for the Company’s products and solutions remains robust, while the trend of growth has moderated from recent historical highs. The Company has secured new orders in its targeted cannabis and electric vehicle markets and is making inroads in working with original equipment manufacturers (“OEMs”) to support semi market demand.

Approximately 75% of the September 30, 2021 backlog is expected to convert to sales in the fourth quarter.

Executing Acquisition Strategy

On October 7, 2021, inTEST acquired substantially all of the assets of Z-Sciences Corp., a developer of ultra-cold storage solutions for the life sciences cold chain market. This small, tuck-in transaction enhances the Company’s technology, adds new talent, and provides a low-cost entry into this fast growing, fragmented market.

On October 28, 2021, inTEST expanded its process technology offerings with the acquisition of Videology Imaging Solutions (“Videology”), a global designer, developer and manufacturer of OEM digital streaming and image capturing solutions. Videology’s trailing twelve-month revenue as of the end of September 2021 was approximately $10 million and provided comparable gross margins with inTEST. The Company expects the acquisition to be approximately $0.05 accretive to diluted earnings per share in the first year, which is net of one-time acquisition related expenses of approximately $0.03 per diluted share that are expected to be recognized in the fourth quarter of 2021.

Both acquired businesses will be integrated into inTEST’s Thermal segment.

Fourth Quarter 2021 Outlook

inTEST’s guidance for the fourth quarter of 2021 includes both GAAP and non-GAAP financial measures. A reconciliation between these GAAP and non-GAAP financial measures accompanies this release.

The Company expects fourth quarter 2021 results, which will include the results of Z-Sciences and Videology for a portion of the quarter, to be in the following ranges:

 

Low

High

Net revenue

$21.5 million

$22.5 million

Gross margin

Consistent with prior quarter

Net earnings per diluted share (GAAP)

$0.10

$0.14

Adjusted net earnings per diluted share (Non-GAAP)

$0.14

$0.18

The foregoing guidance is based on management’s current views with respect to operating and market conditions and customers’ forecasts. Actual results may differ materially from what is provided here today as a result of, among other things, the factors described under “Forward-Looking Statements” below.

Conference Call and Webcast

The Company will host a conference call and webcast today at 8:30 am ET. During the conference call, management will review the financial and operating results and discuss inTEST’s corporate strategy and outlook. A question and answer session will follow.

To listen to the live call, dial (201) 689-8263. In addition, the webcast and slide presentation may be found at: https://ir.intest.com/.

A telephonic replay will be available from 11:30 am ET on the day of the call through Friday, November 12, 2021.

To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13723740 or access the webcast replay via the Company’s website. A transcript will also be posted to the website once available.

About inTEST Corporation

inTEST Corporation is a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, life sciences, semiconductor and telecommunications. Backed by decades of engineering expertise and a culture of operational excellence, inTEST solves difficult thermal, mechanical and electronic challenges for customers worldwide while generating strong cash flow and profits. inTEST’s strategy leverages these strengths to grow organically and with acquisitions through the addition of innovative technologies, deeper and broader geographic reach and market expansion. For more information visit www.intest.com.

Non-GAAP Financial Measures

In addition to disclosing results that are determined in accordance with GAAP, we also disclose non-GAAP financial measures. These non-GAAP financial measures consist of adjusted net earnings (loss), adjusted net earnings (loss) per diluted share, adjusted EBITDA, and adjusted EBITDA margin. Adjusted net earnings (loss) is derived by adding acquired intangible amortization, adjusted for the related income tax expense (benefit), to net earnings (loss). Adjusted net earnings (loss) per diluted share is derived by dividing adjusted net earnings (loss) by diluted weighted average shares outstanding. Adjusted EBITDA is derived by adding acquired intangible amortization, interest expense, income tax expense, depreciation, and stock-based compensation expense to net earnings (loss). Adjusted EBITDA margin is derived by dividing adjusted EBITDA by net revenue. These results are provided as a complement to the results provided in accordance with GAAP. Adjusted net earnings (loss) and adjusted net earnings (loss) per diluted share are non-GAAP financial measures presented to provide investors with meaningful, supplemental information regarding our baseline performance before acquired intangible amortization charges as this expense may not be indicative of our current core business or future outlook. Adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures presented primarily as a measure of liquidity as they exclude non-cash charges for acquired intangible amortization, depreciation and stock-based compensation. In addition, adjusted EBITDA and adjusted EBITDA margin also exclude the impact of interest income or expense and income tax expense or benefit, as these expenses may not be indicative of our current core business or future outlook. These measures may be useful to an investor in evaluating the underlying operating performance of our business. The non-GAAP financial measures presented in this press release are used by management to make operational decisions, to forecast future operational results, and for comparison with our business plan, historical operating results and the operating results of our peers. Reconciliations from net earnings (loss) and net earnings (loss) per diluted share to adjusted net earnings (loss) and adjusted net earnings (loss) per diluted share and from net earnings (loss) to adjusted EBITDA and adjusted EBITDA margin, are contained in the tables below. The non-GAAP financial measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP financial measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements do not convey historical information but relate to predicted or potential future events and financial results, such as statements of our plans, strategies and intentions, or our future performance or goals, that are based upon management’s current expectations. Our forward-looking statements can often be identified by the use of forward-looking terminology such as “believes,” “expects,” “intends,” “may,” “will,” “should,” “plans,” “projects,” “forecasts,” “outlook,” “anticipates” or similar terminology. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

Such risks and uncertainties include, but are not limited to, any mentioned in this press release as well as our ability to realize the potential benefits of acquisitions or dispositions and the successful integration of any acquired operations; our ability to grow our presence in the life sciences, industrial and international markets; the success of our strategy to diversify our business by entering markets outside the semi market; the impact of the COVID-19 pandemic on our business, liquidity, financial condition and results of operations; indications of a change in the market cycles in the Semi Market or other markets we serve; changes in business conditions and general economic conditions both domestically and globally; changes in the demand for semiconductors; our ability to borrow funds or raise capital to finance potential acquisitions; changes in the rates and timing of capital expenditures by our customers; and other risk factors set forth from time to time in our Securities and Exchange Commission filings, including, but not limited to, our annual report on Form 10-K for the year ended December 31, 2020. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks to circumstances only as of the date on which it is made. We undertake no obligation to update the information in this press release to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events.

inTEST CORPORATION
Consolidated Statements of Operations
(In thousands, except share and per share data)
(Unaudited)

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

 

Net revenue

 

$

21,144

 

 

$

14,443

 

 

$

62,520

 

$

38,948

 

Cost of revenue

 

 

10,749

 

 

 

7,993

 

 

 

31,642

 

 

21,564

 

Gross margin

 

 

10,395

 

 

 

6,450

 

 

 

30,878

 

 

17,384

 

Operating expenses:

 

 

 

 

 

 

 

 

Selling expense

 

 

2,841

 

 

 

1,747

 

 

 

7,849

 

 

5,560

 

Engineering and product development expense

 

 

1,334

 

 

 

1,316

 

 

 

4,012

 

 

3,825

 

General and administrative expense

 

 

3,620

 

 

 

2,799

 

 

 

10,550

 

 

8,525

 

Restructuring and other charges

 

 

51

 

 

 

161

 

 

 

303

 

 

207

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

7,846

 

 

 

6,023

 

 

 

22,714

 

 

18,117

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

2,549

 

 

 

427

 

 

 

8,164

 

 

(733

)

Other income (loss)

 

 

(17

)

 

 

6

 

 

 

2

 

 

(44

)

Earnings (loss) before income tax expense (benefit)

 

 

2,532

 

 

 

433

 

 

 

8,166

 

 

(777

)

Income tax expense (benefit)

 

 

357

 

 

 

(25

)

 

 

1,170

 

 

(262

)

 

 

 

 

 

 

 

 

 

Net earnings (loss)

 

$

2,175

 

 

$

458

 

 

$

6,996

 

$

(515

)

 

 

 

 

 

 

 

 

 

Net earnings (loss) per common share – basic

 

$

0.21

 

 

$

0.04

 

 

$

0.67

 

$

(0.05

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – basic

 

 

10,496,188

 

 

 

10,269,995

 

 

 

10,422,851

 

 

10,247,779

 

 

 

 

 

 

 

 

 

 

Net earnings (loss) per common share – diluted

 

$

0.20

 

 

$

0.04

 

 

$

0.65

 

$

(0.05

)

 

 

 

 

 

 

 

 

 

Weighted average common shares and common share equivalents outstanding – diluted

 

 

10,792,290

 

 

 

10,287,562

 

 

 

10,694,351

 

 

10,247,779

 

 

inTEST CORPORATION
Consolidated Balance Sheets
(In thousands, except share and per share data)

 

 

September 30,
2021

 

December 31,
2020

 

 

(Unaudited)

 

 

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

18,743

 

 

$

10,277

 

Trade accounts receivable, net of allowance for doubtful accounts of $211 and $212, respectively

 

 

12,232

 

 

 

8,435

 

Inventories

 

 

9,359

 

 

 

7,476

 

Prepaid expenses and other current assets

 

 

798

 

 

 

776

 

Total current assets

 

 

41,132

 

 

 

26,964

 

Property and equipment:

 

 

 

 

Machinery and equipment

 

 

5,414

 

 

 

5,356

 

Leasehold improvements

 

 

2,908

 

 

 

2,636

 

Gross property and equipment

 

 

8,322

 

 

 

7,992

 

Less: accumulated depreciation

 

 

(5,925

)

 

 

(5,642

)

Net property and equipment

 

 

2,397

 

 

 

2,350

 

Right-of-use assets, net

 

 

5,819

 

 

 

6,387

 

Goodwill

 

 

13,738

 

 

 

13,738

 

Intangible assets, net

 

 

11,503

 

 

 

12,421

 

Restricted certificates of deposit

 

 

100

 

 

 

140

 

Other assets

 

 

40

 

 

 

30

 

Total assets

 

$

74,729

 

 

$

62,030

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

3,849

 

 

$

2,424

 

Accrued wages and benefits

 

 

2,881

 

 

 

1,944

 

Accrued professional fees

 

 

827

 

 

 

776

 

Customer deposits and deferred revenue

 

 

2,082

 

 

 

396

 

Accrued sales commissions

 

 

836

 

 

 

472

 

Current portion of operating lease liabilities

 

 

1,207

 

 

 

1,215

 

Domestic and foreign income taxes payable

 

 

1,121

 

 

 

825

 

Other current liabilities

 

 

741

 

 

 

804

 

Total current liabilities

 

 

13,544

 

 

 

8,856

 

Operating lease liabilities, net of current portion

 

 

5,332

 

 

 

6,050

 

Deferred tax liabilities

 

 

1,701

 

 

 

1,922

 

Other liabilities

 

 

436

 

 

 

450

 

Total liabilities

 

 

21,013

 

 

 

17,278

 

Commitments and Contingencies

 

 

 

 

Stockholders’ equity:

 

 

 

 

Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding

 

 

 

 

 

 

Common stock, $0.01 par value; 20,000,000 shares authorized; 10,819,294 and 10,562,200 shares issued, respectively

 

 

108

 

 

 

106

 

Additional paid-in capital

 

 

28,962

 

 

 

26,851

 

Retained earnings

 

 

24,106

 

 

 

17,110

 

Accumulated other comprehensive earnings

 

 

744

 

 

 

889

 

Treasury stock, at cost; 33,077 shares

 

 

(204

)

 

 

(204

)

Total stockholders’ equity

 

 

53,716

 

 

 

44,752

 

Total liabilities and stockholders’ equity

 

$

74,729

 

 

$

62,030

 

 

inTEST CORPORATION
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

 

 

Nine Months Ended

September 30,

 

 

2021

 

2020

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

Net earnings (loss)

 

$

6,996

 

 

$

(515

)

Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

 

2,166

 

 

 

2,378

 

Provision for excess and obsolete inventory

 

 

154

 

 

 

410

 

Foreign exchange loss

 

 

36

 

 

 

33

 

Amortization of deferred compensation related to stock-based awards

 

 

1,094

 

 

 

480

 

Loss on disposal of property and equipment

 

 

20

 

 

 

56

 

Deferred income tax benefit

 

 

(221

)

 

 

(81

)

Changes in assets and liabilities:

 

 

 

 

Trade accounts receivable

 

 

(3,874

)

 

 

(237

)

Inventories

 

 

(2,051

)

 

 

(146

)

Prepaid expenses and other current assets

 

 

(26

)

 

 

95

 

Restricted certificates of deposit

 

 

40

 

 

 

 

Other assets

 

 

(10

)

 

 

(5

)

Accounts payable

 

 

1,425

 

 

 

215

 

Accrued wages and benefits

 

 

942

 

 

 

18

 

Accrued professional fees

 

 

52

 

 

 

47

 

Customer deposits and deferred revenue

 

 

1,697

 

 

 

936

 

Accrued sales commissions

 

 

366

 

 

 

(2

)

Operating lease liabilities

 

 

(918

)

 

 

(977

)

Domestic and foreign income taxes payable

 

 

302

 

 

 

(240

)

Other current liabilities

 

 

(60

)

 

 

(60

)

Other liabilities

 

 

(7

)

 

 

(5

)

Net cash provided by operating activities

 

 

8,123

 

 

 

2,400

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

Purchase of property and equipment

 

 

(577

)

 

 

(520

)

Net cash used in investing activities

 

 

(577

)

 

 

(520

)

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

Proceeds from stock options exercised

 

 

1,019

 

 

 

 

Repurchases of common stock

 

 

 

 

 

(74

)

Proceeds from Paycheck Protection Program loans

 

 

 

 

 

2,829

 

Repayments of Paycheck Protection Program loans

 

 

 

 

 

(2,829

)

Proceeds from revolving credit facility

 

 

 

 

 

2,800

 

Repayments of revolving credit facility

 

 

 

 

 

(2,800

)

Net cash provided by (used in) financing activities

 

 

1,019

 

 

 

(74

)

 

 

 

 

 

Effects of exchange rates on cash

 

 

(99

)

 

 

55

 

 

 

 

 

 

Net cash provided by all activities

 

 

8,466

 

 

 

1,861

 

Cash and cash equivalents at beginning of period

 

 

10,277

 

 

 

7,612

 

Cash and cash equivalents at end of period

 

$

18,743

 

 

$

9,473

 

 

 

 

 

 

Cash payments for:

 

 

 

 

Domestic and foreign income taxes

 

$

1,053

 

 

$

58

 

 

inTEST CORPORATION
Reconciliation of Non-GAAP Financial Measures
(In thousands, except per share and percentage data)
(Unaudited)

 

Reconciliation of Net Earnings (Loss) (GAAP) to Adjusted Net Earnings (Loss) (Non-GAAP) and Net Earnings (Loss)

Per Share – Diluted (GAAP) to Adjusted Net Earnings (Loss) Per Share – Diluted (Non-GAAP):

 

 

Three Months Ended

 

9/30/2021

 

9/30/2020

 

6/30/2021

 

 

 

 

 

 

Net earnings (GAAP)

$

2,175

 

 

$

458

 

 

$

2,609

 

Acquired intangible amortization

 

309

 

 

 

307

 

 

 

305

 

Tax adjustments

 

(4

)

 

 

(15

)

 

 

(4

)

Adjusted net earnings (Non-GAAP)

$

2,480

 

 

$

750

 

 

$

2,910

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

10,792

 

 

 

10,288

 

 

 

10,765

 

 

 

 

 

 

 

Net earnings per share – diluted:

 

 

 

 

 

Net earnings (GAAP)

$

0.20

 

 

$

0.04

 

 

$

0.24

 

Acquired intangible amortization

 

0.03

 

 

 

0.03

 

 

 

0.03

 

Tax adjustments

 

 

 

 

 

 

 

 

Adjusted net earnings per share – diluted (Non-GAAP)

$

0.23

 

 

$

0.07

 

 

$

0.27

 

Contacts

inTEST Corporation

Duncan Gilmour

Chief Financial Officer and Treasurer

Tel: (856) 505-8999

Investors:

Deborah K. Pawlowski

Kei Advisors LLC

[email protected]
Tel: (716) 843-3908

Read full story here

Sign Up for Our Newsletters

Get notified of the best deals on our WordPress themes.

You May Also Like

GrowGeneration Acquires Aqua Serene, Expands Footprint in Oregon's Southern "Green Belt"

Acquisition Brings Number of GrowGen Locations Nationwide to 5 7 DENVER, July…

AWH to Hold Second Quarter 2021 Earnings Conference Call on Tuesday, August 10, 2021

NEW YORK, July 21, 2021 /PRNewswire/ – Ascend Wellness Holdings, Inc. (“AWH” or the…